Please RT: Postdoctoral position available in mycobacteriology and single-cell technologies in the Microbial Individuality and Infection Lab at the Institut Pasteur in Paris. Please see details below.

TB deaths are increasing for the first time in over a decade, and we are no longer on track to #endTB by 2030. Guy Marks AO, president at The Union, attests that we must re-focus our efforts on new strategies and evidence-based innovations.

We still have open #PhD & #postdoc positions in quantitative cell biology of bacterial shape, size, growth. Bonus for experience in optics/microscopy (e.g. #SPT, #QPM), coding, bacterial cell & mol bio. vanteeffelenlab.org @Umontreal bit.ly/3DoZBB7 Please RT!

We had the pleasure of Giulia Manina giving a talk at ISMB-MRL and visiting our mycobacteria research labs. Thank you Giulia! #mycobacteria #amr #science

The units of Mariana Alonso, Jean-Baptiste Masson (Neuroscience Department - Institut Pasteur) and my core facility have an opening for a join postdoc / engineer! RTs appreciated.

Now online our article on #microfluidics and #mycobacterial individuality, Springer Nature > Scientific Reports: rdcu.be/cZInt!

AMR is a huge issue, and we need your help to fight it. Participate with World Health Organization (WHO) in World Antimicrobial Awareness Week, and prevent the spread of drug-resistant infections. Show your support by wearing blue and sharing this campaign with others. 🔷 #WAAW2022

📆 25-26 January 📍 Paris ERA4TB's 6th Consortium Meeting is just around the corner! Looking forward to meeting in Paris more than 100 partners’ representatives again in this 2-day F2F event to discuss the latest project updates Read more👉era4tb.org/era4tb-6th-con… #TB #H2020

🎉As the 6th ERA4TB Consortium Meeting in Paris comes to an end we'd like to thank all participants for another successful event! We look forward to continuing our work towards better TB treatments over the next 3 years and to our next consortium meeting this summer! #TB #H2020

This #WorldTBDay, let's work together with an #AimToEndTB once and for all. #TBDay #YesWeCanEndTB

Pleased that our preprint is out! Thanks to everyone involved in this project aimed at tackling tuberculosis by targeting phenotypic variation. biorxiv.org/content/10.110…

Please RT! We are recruiting! Grant-funded positions to look at a) TB vaccine candidate development and b) TB antibiotic tolerance. Two SRA positions (links in next tweet). Ideal candidate will be curious, hard-working and fun to collaborate with. Full training provided.

The ERA4TB 8th Consortium Meeting has just kicked off with a welcome by Ulrika Simonsson and the Project Leadership! Coming up: the latest progression updates and assets forecasts for the next months Uppsala universitet Servicio de Investigación UC3M GSK Innovative Health Initiative IMI AMR ACCELERATOR

And the ERA4TB 8th Consortium Meeting is over! Thanks to all our partners for their attendance and outstanding contributions during these two days of productive meetings and discussions 👏 Servicio de Investigación UC3M Uppsala universitet GSK España Innovative Health Initiative IMI AMR ACCELERATOR #Tuberculosis

Delighted to share our latest research on #tuberculosis therapeutics via "pheno-tuning" published in Nature Communications. Read more here: rdcu.be/dH9il!

To learn more about our paper rdcu.be/dH9il, visit this blog post on Research Communities: communities.springernature.com/posts/descript…

🔜Next Cell Biology & Infection seminar next Monday Vivek V Thacker from Uni Heidelberg Plenty of room in the middle’: microphysiologicalmodels as enabling platforms to study infections in tissues Invited by Giulia Manina

📰 Check out our latest news article describing our recent annual consortium meeting and our first ever joint symposium with fellow Innovative Health Initiative project UNITE4TB at Uppsala University ➡️Read our latest news now: era4tb.org/era4tb-celebra… #Tuberculosis #TB #TBresearch #drugdevelopment

Thanks to all partners of the #ANR TREATABLE consortium for their participation and fruitful discussions during our 2nd annual meeting at the Institut Pasteur. Merging #DrugDiscovery, #Microfluidics, and #SingleCells to improve #TB treatment. CERMN Elvesys — Microfluidics innovation center Giulia Manina

Come join our team at the Institut Pasteur in Paris! We are hiring a postdoc to investigate the single-cell biology of M. tuberculosis. More information is available here: research.pasteur.fr/en/job/postdoc…